秉持医者初心,以无创诊断造福MAFLD患者  

Doctors'original intentionality in adherence to non-invasive diagnoses benefits MAFLD patients

作　　者：张淮 郑明华[1,2] Zhang Huai;Zheng Minghua(Department of Biostatistics and Records Room,Medical Quality Management Office,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;Department of Hepatology,MAFLD Research Center,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China)

机构地区：[1]温州医科大学附属第一医院病案信息统计室,医疗质量管理处,温州325000 [2]温州医科大学附属第一医院感染内科/肝病中心,温州325000

出　　处：《中华肝脏病杂志》2023年第12期1233-1234,共2页Chinese Journal of Hepatology

摘　　要：准确诊断代谢相关脂肪性肝病及其严重程度可有效延缓疾病进展并对治疗有重要的指导价值。近年来,代谢相关脂肪性肝病的无创诊断研究取得了长足进展,提示我们肝病领域人员不仅要充分发挥自身专业优势,还需积极联合其他领域人员,探索不同方式的高性能无创诊断方法,以便早发现、早诊断、早治疗代谢相关脂肪性肝病。Precisely diagnosing metabolic dysfunction-associated fatty liver disease(MAFLD)and its severity degree can effectively delay disease progression and have important guiding values for treatment.In recent years,research on non-invasive diagnosis of metabolic dysfunction-associated fatty liver disease has made great progress,suggesting that we should not only give full play advantage to professional personnel in the field of liver disease but also actively cooperate with personnel in other fields to explore different high-performance non-invasive diagnostic methods to achieve early detection,diagnosis,and treatment.

关 键 词：代谢相关脂肪性肝病 无创诊断 多学科研究 

分 类 号：R575.5[医药卫生—消化系统]